Botulinum Toxin Market Size By Product (Botulinum Toxin A, Botulinum Toxin B), By Application (Medical, Aesthetic), By Gender (Female, Male), By Age (13-19, 20-29, 30-39, 40-54, 55 and Above), By End-use (Hospitals, Dermatology Clinics, Spas & Cosmetic Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Jul 2020  |  Report ID: GMI3408  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 164   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Botulinum Toxin Market size exceeded USD 4.9 billion in 2019 and is poised to grow at over 8.9% CAGR between 2020 and 2026. The rising number of non-invasive cosmetic procedures will drive the market growth.
 

Another major factor driving the growth trend in the market is a high consciousness amongst individuals regarding their appearance. Growing patient preference towards non-invasive or minimally treatments coupled with development of novel products will thus accelerate the market progress.
 

Botulinum Toxin Market

Get more details on this report - Request Free Sample PDF
 

Availability of minimally invasive surgeries will offer growth opportunities for the market

The increasing quality of care along with availability of minimally invasive surgeries by aesthetic surgeons has contributed to significant growth in procedural volume. Furthermore, aging population, rising incidence of aesthetic problems such as lateral canthal lines, crow’s feet and introduction of cost-effective aesthetic products are also boosting the botulinum toxin market demand. Focus of market players to develop and add new products to cosmetic procedures will further contribute significantly to the market growth. However, side effects and lack of reimbursement policies may restrain the industry growth.
 

Botulinum Toxin Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: USD 4.9 Billion
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: 8.9% 2026 Value Projection: USD 8.9 billion
Pages: 164 Tables, Charts & Figures: 302
Geographies covered (18): U.S., Canada, Germany, UK, France, Spain, Italy, Turkey, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Egypt, Iran
Segments covered: Product, Application, Gender, Age Group, End-use and Region
Companies covered (10): Allergan, Eisai Co., Ltd, Hugel, Inc., Hugh Source International Ltd., Ipsen, Medytox, Inc., Merz Pharma, Evolus, Inc., AbbVie, Revance Therapeutics, Inc.
Growth Drivers:
  • Increasing applications in the cosmetic and therapeutic procedures
  • Rising awareness pertaining to therapeutic and cosmetic application of botulinum toxin
  • Increasing number of products approvals and launch
  • Increasing demand for minimally invasive procedures
Pitfalls & Challenges:
  • High cost of botulinum toxin procedures
  • Side effects associated with these procedures

Get more details on this report - Request Free Sample PDF
 

Botulinum toxin A regulate greater efficacy and safer in long lasting results

The botulinum toxin A segment dominated the market share in 2019 and is estimated to grow substantially during the forecast period due to growing application in medical & aesthetic field and rise in interest of manufacturers to develop such products. Various botulinum toxin A products are commercially available in the market that include Botox and Dysport and have been clinically proven to be effective, safe in long terms with minimal side effects.
 

High consciousness amongst individuals regarding their appearance will boost the growth opportunities

Aesthetic application segment will witness a growth rate of around 8.1% through 2026 driven by rising demand for aesthetic surgeries. The rising awareness regarding the various cosmetic procedures to reduce signs of aging especially in women will drive the product demand. Moreover, an increase in concern of people regarding their appearance in developed and developing regions will further increase the number of cosmetic surgeries, augmenting the market revenue.
 

Major influence of social media on changing beauty trends will propel the botulinum toxin market growth

Botulinum Toxin Market By Age Group

Get more details on this report - Request Free Sample PDF
 

Age group between 20-29 years tend to opt for various cosmetic surgeries and is anticipated to exhibit a robust growth of more than 8.5% till 2026. Major influence of social media on changing beauty trends coupled with rising awareness among individuals regarding various aesthetic procedures will drive the segment growth.
 

Rising trends in middle-aged women to stay young will boost the segmental growth

Female segment is leading the global botulinum toxin industry with the largest value of USD 4.6 billion in 2019 on account of rising trends in females for skin rejuvenation at middle-age. Signs of aging such as forehead lines, frown lines and crow’s feet among others can be reduced by performing aesthetic procedures.
 

High demand for surgeries that are being performed in dermatological clinics will upsurge the market demand

Dermatology clinics segment held around 45% market share in 2019 attributed to rise in number of cosmetic procedures across the world. Furthermore, increasing prevalence of cervical dystonia will boost the demand for minimally invasive treatments that are being performed in the dermatological clinics.
 

High disposable income along with increasing number of aesthetic procedures will boost the regional market revenue

Botulinum Toxin Market By Region

Get more details on this report - Request Free Sample PDF
 

North America botulinum toxin market accounted for considerable revenue share in 2019 and is predicted to reach a valuation of over USD 6.5 billion by 2026 led by growing disposable income coupled with availability of variety of aesthetic procedures. Additionally, rapid advancements in medical aesthetic procedures have been observed over the last few years in United States, thereby fostering the industry growth. The advanced technologies have introduced a wide range of solutions and products to patients seeking medical assistance.
 

Adoption of inorganic growth strategies to create a global footprint will pave growth opportunities for companies operating in the botulinum toxin industry

Prominent players operating in the market include Allergan, Merz Pharma, Eisai Co., Ltd., Galderma S.A., Hugel Inc., Medytox Inc., Hugh Source International ltd., Ipsen and Revance Therapeutics, Inc. These companies bank on various strategies including acquisitions, collaborations, partnerships, and mergers to create a global footprint and ward off the market competition.
 

Some of the recent industry developments:

  • In May 2019, Merz Pharma received a European approval of its Xeomin, an incobotulinum toxin A for the symptomatic treatment of chronic sialorrhea. Also, Xeomin is the only neurotoxin to be approved in European region for the above-mentioned indication. This enabled the company to explore the untapped countries in Europe and expand its market share.
     
  • In September 2018, Allergan acquired Bonti Inc, a biotechnology company that focused on commercialization and development of a novel and fast acting neurotoxin program for therapeutic and aesthetic applications. This acquisition enabled Allergan to obtain Bonti’s two pipeline botulinum neurotoxin as well as expanded its business portfolio and strengthened its market position.
     

The botulinum toxin market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

Market, By Product

  • Botulinum toxin A
  • Botulinum toxin B

Market, By Application

  • Medical
  • Aesthetic

Market, By Gender

  • Female
  • Male

Market, By Age Group

  • 13-19
  • 20-29
  • 30-39
  • 40-54
  • 55 and above

Market, By End-use

  • Hospitals
  • Dermatology Clinics
  • Spas & cosmetic centers

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Turkey
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Egypt
    • Iran

 

Frequently Asked Questions (FAQ) :

The market size of botulinum toxin exceeded USD 4.9 billion in 2019.
The industry share of botulinum toxin is poised to grow at over 8.9% CAGR between 2020 and 2026.
North America market accounted for considerable revenue share in 2019 and is predicted to reach a valuation of over USD 6.5 billion by 2026.
According to the analysts at GMI, Aesthetic application segment will witness a growth rate of around 8.1% through 2026.
Prominent players operating in the industry include Allergan, Merz Pharma, Eisai Co., Ltd., Galderma S.A., Hugel Inc., Medytox Inc., Hugh Source International ltd., Ipsen and Revance Therapeutics, Inc.
Major influence of social media on changing beauty trends coupled with rising awareness among individuals regarding various aesthetic procedures drives the age group between 20-29 years to opt for various botox surgeries.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Jul 2020
  • Pages: 164
  • Tables: 286
  • Charts / Figures: 16
  • Companies covered: 10
  • Countries covered: 18

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X